128 related articles for article (PubMed ID: 26670479)
21. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.
Ferrannini E; Gastaldelli A; Miyazaki Y; Matsuda M; Mari A; DeFronzo RA
J Clin Endocrinol Metab; 2005 Jan; 90(1):493-500. PubMed ID: 15483086
[TBL] [Abstract][Full Text] [Related]
22. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies.
Ahrén B; Pacini G
Eur J Endocrinol; 2004 Feb; 150(2):97-104. PubMed ID: 14763905
[TBL] [Abstract][Full Text] [Related]
23. Changes in insulin sensitivity and secretion after sleeve gastrectomy.
Casella G; Soricelli E; Castagneto-Gissey L; Redler A; Basso N; Mingrone G
Br J Surg; 2016 Feb; 103(3):242-8. PubMed ID: 26550995
[TBL] [Abstract][Full Text] [Related]
24. Toward an integrated phenotype in pre-NIDDM.
Bergman RN; Watanabe R; Rebrin K; Ader M; Steil G
Diabet Med; 1996 Sep; 13(9 Suppl 6):S67-77. PubMed ID: 8894486
[TBL] [Abstract][Full Text] [Related]
25. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
Festa A; Williams K; Hanley AJ; Haffner SM
Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
[TBL] [Abstract][Full Text] [Related]
26. Insulin resistance & secretion in subjects with normal fasting plasma glucose.
Hsieh CH; Hung YJ; Wu CZ; Lee SS; Lee CH; Chen CY; Li JC; Kuo SW; Kuo KL; Pei D
Indian J Med Res; 2006 Nov; 124(5):527-34. PubMed ID: 17213521
[TBL] [Abstract][Full Text] [Related]
27. Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects.
Mari A; Schmitz O; Gastaldelli A; Oestergaard T; Nyholm B; Ferrannini E
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1159-66. PubMed ID: 12388151
[TBL] [Abstract][Full Text] [Related]
28. First-phase insulin secretion has limited impact on postprandial glycemia in subjects with type 2 diabetes: correlations between hyperglycemic glucose clamp and meal test.
Rave K; Sidharta PN; Dingemanse J; Heinemann L; Roggen K
Diabetes Technol Ther; 2010 Feb; 12(2):117-23. PubMed ID: 20105041
[TBL] [Abstract][Full Text] [Related]
29. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.
Utzschneider KM; Prigeon RL; Faulenbach MV; Tong J; Carr DB; Boyko EJ; Leonetti DL; McNeely MJ; Fujimoto WY; Kahn SE
Diabetes Care; 2009 Feb; 32(2):335-41. PubMed ID: 18957530
[TBL] [Abstract][Full Text] [Related]
30. Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism.
Tassone F; Procopio M; Gianotti L; Visconti G; Pia A; Terzolo M; Borretta G
Diabet Med; 2009 Oct; 26(10):968-73. PubMed ID: 19900227
[TBL] [Abstract][Full Text] [Related]
31. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
Mari A
Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
[TBL] [Abstract][Full Text] [Related]
32. Impact of one-hour postchallenge glucose on the relationship between insulin sensitivity and secretion.
Sato Y; Oka R; Nakasone Y; Katakura M; Yamauchi K; Aizawa T
Endocr J; 2015; 62(7):573-83. PubMed ID: 26052138
[TBL] [Abstract][Full Text] [Related]
33. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K
Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
[TBL] [Abstract][Full Text] [Related]
34. Expanding the clinical use of standard OGTT: the percentage increment of 2 h with respect to fasting glucose as an index of β-cell dysfunction.
Carnevale Schianca GP; Mella R; Scaglia E; Bigliocca M; Colli E; Fra GP; Bartoli E
Diabetes Metab Res Rev; 2011 Mar; 27(3):262-8. PubMed ID: 21309049
[TBL] [Abstract][Full Text] [Related]
35. Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance.
Ehrmann DA; Breda E; Cavaghan MK; Bajramovic S; Imperial J; Toffolo G; Cobelli C; Polonsky KS
Diabetologia; 2002 Apr; 45(4):509-17. PubMed ID: 12032626
[TBL] [Abstract][Full Text] [Related]
36. The dynamic insulin sensitivity and secretion test--a novel measure of insulin sensitivity.
McAuley KA; Berkeley JE; Docherty PD; Lotz TF; Te Morenga LA; Shaw GM; Williams SM; Chase JG; Mann JI
Metabolism; 2011 Dec; 60(12):1748-56. PubMed ID: 21704347
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiological Characteristics Underlying Different Glucose Response Curves: A Latent Class Trajectory Analysis From the Prospective EGIR-RISC Study.
Hulman A; Witte DR; Vistisen D; Balkau B; Dekker JM; Herder C; Hatunic M; Konrad T; Færch K; Manco M
Diabetes Care; 2018 Aug; 41(8):1740-1748. PubMed ID: 29853473
[TBL] [Abstract][Full Text] [Related]
38. Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic finnish offspring of type 2 diabetic individuals.
Lorenzo C; Haffner SM; Stancáková A; Laakso M
J Clin Endocrinol Metab; 2010 Nov; 95(11):5082-90. PubMed ID: 20702522
[TBL] [Abstract][Full Text] [Related]
39. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
[TBL] [Abstract][Full Text] [Related]
40. Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects.
Haap M; Heller E; Thamer C; Tschritter O; Stefan N; Fritsche A
Eur J Clin Nutr; 2006 Jun; 60(6):734-9. PubMed ID: 16391583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
